About: Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 07 February 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) наукова стаття, опублікована в лютому 2008 (uk) artículu científicu espublizáu en febreru de 2008 (ast) scientific article published on 07 February 2008 (en) مقالة علمية نشرت في 07 فبراير 2008 (ar)
publication date	wds:Q37091185-9D787719-EF55-472F-99B0-BFC7CF92B0FA
publication date	2008-02-07 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37091185-5366BEF0-36A5-47E1-99F0-AEF1E7B1BE73
language of work or name	English
cites work	wds:Q37091185-CF9E4EF5-6FFF-4007-81E7-71A7A30DADCF
cites work	Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT.
author name string	wds:Q37091185-12798730-7D9A-499A-AC3D-0E37D02E07C8 wds:Q37091185-13D152FF-50DB-4D5D-AEEE-53010FEA1F13 wds:Q37091185-3A894D45-6293-4148-936E-9FD6EF924A8C wds:Q37091185-AC59FC75-A3CD-42B6-B051-1AC94656C4DA
author name string	Andre T Baron Jason A Wilken Nita J Maihle Jacqueline M Lafky
rdfs:label	Clinical implications of the ErbB/epidermal growth factor (nl) Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer (en)
skos:prefLabel	Clinical implications of the ErbB/epidermal growth factor (nl) Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer (en)
name	Clinical implications of the ErbB/epidermal growth factor (nl) Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer (en)
title	wds:Q37091185-3B2BA855-B5DF-467F-A7C2-79CBD6ED86E6
title	Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer (en)
page(s)	wds:Q37091185-AFD006C9-59B4-4B42-8BA1-9799021AC204
page(s)	232-265
instance of	wds:Q37091185-1305fd1a-c879-4267-b140-d8b5f8fb5c0d wds:Q37091185-DAC1CC99-0F36-4B8F-AEBB-9CF78DD59F52
instance of	review article scholarly article
main subject	wds:Q37091185-987072C6-F753-4ADD-8C98-03D96F1FFDDB
main subject	ovarian neoplasm
PubMed ID	wds:Q37091185-5FAB607F-B562-43C6-B654-9B33DE85C932
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18291115
PubMed ID	18291115
published in	wds:Q37091185-2ACAA169-6869-4EAC-B36C-9CFB283A6FD1
published in	Biochimica et Biophysica Acta
issue	wds:Q37091185-EB5DDDBA-8A96-4C69-A308-D215D0BA803B
volume	wds:Q37091185-E121C2DD-D9CF-4488-B3C6-1B6C61C7AB9B
issue	2
volume	1785
DOI	wds:Q37091185-C15CA46F-31B6-4727-995D-5403DB7A7652
DOI	http://dx.doi.org/10.1016/J.BBCAN.2008.01.001
DOI	10.1016/J.BBCAN.2008.01.001
ResearchGate publication ID	wds:Q37091185-87E5004A-C293-41E3-943B-AC83DF76776C
ResearchGate publication ID	5561318
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37091185
is cites work of	An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells Animal models for IgE-meditated cancer immunotherapy Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells Rapamycin by itself and additively in combination with carboplatin inhibits the growth of ovarian cancer cells The epidermal growth factor receptor conundrum EGFR/HER-targeted therapeutics in ovarian cancer Ovarian cancer biomarker discovery based on genomic approaches The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form. The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer Differential effects of EGFR ligands on endocytic sorting of the receptor. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways Increased DNA methyltransferase activity and DNA methylation following Epidermal Growth Factor stimulation in ovarian cancer cells Primary trastuzumab resistance: new tricks for an old drug Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells EGF receptor trafficking: consequences for signaling and cancer Clinical trials and future potential of targeted therapy for ovarian cancer Epidermal growth factor-induced GnRH-II synthesis contributes to ovarian cancer cell invasion Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid EGFR isoforms and gene regulation in human endometrial cancer cells Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck High incidence of ErbB3, ErbB4, and MET expression in ovarian cancer Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges. Identification of an exon 4-deletion variant of epidermal growth factor receptor with increased metastasis-promoting capacity Revisiting the seed and soil in cancer metastasis Investigational agents in development for the treatment of ovarian cancer Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways Time-resolved fluorescence resonance energy transfer (TR-FRET) to analyze the disruption of EGFR/HER2 dimers: a new method to evaluate the efficiency of targeted therapy using monoclonal antibodies Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software